newsfilter
← Latest News
PR Newswire·

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Inozyme Pharma, Inc. (Nasdaq: INZY) announced today that BioMarin has entered into a definitive...